Modification or dose or treatment duration has no impact on outcome of AML patients: preliminary results of the UK NCRI AML 14 trail

Research output: Contribution to journalAbstract

Authors

  • AK Burnett
  • Donald Milligan
  • AG Prentice
  • A Goldstone
  • A McMullin

Details

Original languageEnglish
Pages (from-to)162a
JournalBlood
Volume106
Issue number11
Publication statusPublished - 1 Jan 2005